Autologous Ex Vivo Lentiviral Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I Provides Sustained Efficacy with a Favorable Safety Profile

J Hum Immun (2026) 2 (CIS2026): eCIS2026abstract.4.
Currently there are no citedby results. Try again later.